Form 8-K Pulse Biosciences, Inc. For: Nov 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Pulse Biosciences (PLSE) Reports Q3 Loss of $0.21
November 15, 2016 7:50 AM ESTPulse Biosciences (NASDAQ: PLSE) reported Q3 EPS of ($0.21), versus ($0.10) reported last year.
Cash, cash equivalents, and investments totaled $18.7 million at September 30, 2016 compared to $20.7 million and $3.6 million at June 30, 2016 and December 31, 2015, respectively.
For earnings history and earnings-related data on Pulse Biosciences (PLSE) click here.
... More